| FAQ/Help |
| Calendar |
| Search |
| Today's Posts |
12-22-2016, 05:53 AM
|
#1 | ||
|
|||
|
News Gatherer
Community Support Team
|
Neurology Advisor Adjunctive Safinamide Increases On Time in Parkinson's Disease Neurology Advisor The addition of safinamide to levodopa therapy for Parkinson's disease (PD) increases â??onâ?? time without troublesome dyskinesia, according to results of a randomized clinical trial published in JAMA Neurology.1 The investigators, led by Anthony Schapira ... More... |
||
|
 Reply With Quote
|
| Reply |
|
|
Similar Threads
|
||||
| Thread | Forum | |||
| CHMP Recommends Approval of Xadago™ (Safinamide) to Treat Parkinson´s Disease in EU | Parkinson's Disease | |||
| ß-asarone increases l-dopa in parkinson's disease | Parkinson's Disease | |||
| Safinamide in Idiopathic Parkinson's Disease (IPD) With Motor Fluctuations, as Add-on | Parkinson's Disease Clinical Trials | |||
| Promising Data on Cognitive Effects of Safinamide in Early Parkinson's Disease | Parkinson's Disease Clinical Trials | |||
Adjunctive Safinamide Increases On Time in Parkinson's Disease - Neurology Advisor
Linear Mode
